We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Urology

Journal Scan / Research · July 07, 2021

Transcutaneous Sacral Electrical Stimulation vs Oxibutynin for the Treatment of Paediatric Overactive Bladder

Journal of Pediatric Urology


Additional Info

Disclosure statements are available on the authors' profiles:

Journal of Pediatric Urology
Transcutaneous Sacral Electrical Stimulation Versus Oxibutynin for the Treatment of Overactive Bladder in Children
J Pediatr Urol 2021 Jun 11;[EPub Ahead of Print], I Casal-Beloy, MA García-Novoa, M García González, B Acea Nebril, I Somoza Argibay

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading